|
Leucine Rich Bio and Vittartha Life Science partner to advance drug discovery and development
|
|
Our Bureau, Bengaluru
June 30 , 2017
|
|
|
Leucine Rich Bio, a genomics company, has partnered with Vittarthaa
Life Sciences, a drug discovery and development company, focusing on
identifying unmet clinical needs to develop pharmaceutical molecules.
The
Bengaluru-based Leucine has developed analysis and interpretation
pipelines for next generation sequencing and microarray data. Apart from
that, the company has provided customized meta-analysis of publicly
available data to cater to its client base which is spread across the
globe. With strong systems biology, molecular biology and genomics
background, the company can provide an umbrella of bio-informatics and
other data solutions to its clients.
For Vittartha, all research
programs are based on integrated approach towards target-based
discovery strategies and phenotypic screening for end-point evaluation.
It is also focused on innovative discovery and development approaches
for progressing molecules into market. The discovery programme devises
multi-parametric, phenotypic panel assay screening efficacy that are
target based and de-risk toxicity at early stages. The company engages
the customer at early stages of drug development providing suitable
platforms for mapping the molecular mechanisms that enable to create
program objective, target product profile and outline milestones
decisions.
Both the companies have announced collaboration in
order to provide pharmaceutical, nutraceuticals and biotechnology
companies a combined portfolio of research solutions under one platform.
This would enable the potential clients to get maximum benefit for its
research projects. “With our association with Vitthartha we can service
the pharmaceutical and biotechnology companies in a much more focused
manner”, said Dr Debojyoti Dhar, director, Leucine Rich Bio.
“Today’s
global market demands a thorough molecular based approach with clinical
evidence based products and drugs. Primary focus and key strengths of
both the companies complement each other for today’s discovery and
development. This collaboration will be mutually benefits to deliver
tailor made precise requirements for every research programme”, said Dr
Yogananda, director, Vittartha Life Science.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|